CCL20 and hematologic disorder: Of particular interest is the new T cell therapy for solid tumors, similar to the Car-T in hematological malignancies, which could be used in small dysplastic lesions of the larynx, especially when CCL20 and CCR4 are the most important gene alterations observed in dysplasia.